Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Edesa Biotech Inc | EDSA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.31 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 2.4603 - 8.61 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 4.31 | USD |
Edesa Biotech Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 13.67M | - | - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Edesa Biotech News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EDSA Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.34 | 4.7255 | 4.2501 | 4.38 | 2,407 | -0.03 | -0.69% |
1 Month | 4.3201 | 4.9566 | 4.0165 | 4.45 | 5,907 | -0.0101 | -0.23% |
3 Months | 4.55 | 5.99 | 3.88 | 4.84 | 12,510 | -0.24 | -5.27% |
6 Months | 3.40 | 6.46 | 2.50 | 4.42 | 21,183 | 0.91 | 26.76% |
1 Year | 8.12 | 8.61 | 2.4603 | 5.20 | 63,653 | -3.81 | -46.92% |
3 Years | 38.85 | 84.00 | 2.4603 | 58.45 | 395,070 | -34.54 | -88.91% |
5 Years | 36.05 | 133.70 | 2.4603 | 54.06 | 412,101 | -31.74 | -88.04% |
Edesa Biotech Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side-effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients. |